Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6011.5000 -59.50 (-0.98%)
NSE Jan 23, 2026 15:31 PM
Volume: 460.5K
 

6011.50
-0.98%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues fell 3% YoY to | 1067 crore against I-direct estimate of | 1041 crore. Both generic CS segments registered de-growth of 1%, 3%, respectively, due to impact of capacity constraints & import alert EBITDA margins declined 224 bps to 33.9% (I-direct estimate: 36.8%) mainly due to increase in other expenditure, which included forex...
Divi's Laboratories .. has an average target of 6270.00 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended